Purchase Order HHSN275201700984P

<p>The National Institute of Child Health and Human Development awarded a purchase order to Advanced Cell Diagnostics, Inc. for $10,000.00 on September 22, 2017, with completion by December 22, 2017. No set-aside was used. Performance occurs in Bethesda, Maryland. The order is for RNA detection technologies and related diagnostic products, consistent with Advanced Cell Diagnostics' RNAscope platform and specialized molecular pathology solutions supporting NIH research programs.</p>

The National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), has awarded a $16,732 firm-fixed-price purchase order to Advanced Cell Diagnostics, Inc. (ACD) for gene expression analysis study services. The contract, which does not have a set-aside designation, will support the agency's research efforts in areas such as cancer, infectious diseases, neuroscience, and genomics. As a molecular diagnostics company specializing in RNA...

The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $3,857.60 firm fixed price purchase order to Advanced Cell Diagnostics, Inc., doing business as ACD, a division of Bio-Techne Corporation, doing business as Bio-Techne. The contract is for the delivery of RNAscope probes, reagent kits, and related products to support research efforts being conducted at the agency's Bethesda, Maryland campus. As the leading...

This firm-fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian federal agency, to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation. The $10,488.08 contract is for the provision of ACD's proprietary RNAscope technology and related products, which enable the visualization and quantification of RNA biomarkers. This contract supports biomedical research efforts across various National Institutes of...

<p>The National Institute of Neurological Disorders and Stroke awarded a purchase order to Advanced Cell Diagnostics, Inc. for $4,025.00 on July 29, 2017, for a hybridization system with batch slide system, with final completion by September 8, 2017. Performance occurs in Bethesda, Maryland. No set-aside applied to this firm fixed price acquisition.</p>

This contract award is to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation, by the National Institute of Child Health and Human Development (NICHD), a component of the National Institutes of Health (NIH). The $5,110.00 firm-fixed-price purchase order is for ACD's proprietary RNAscope technology and related products to support biomedical research efforts across various NIH institutes and other federal agencies. ACD's expertise in RNA detection has made it a valuable...

The National Institutes of Health's National Institute of Child Health and Human Development awarded a $14,600.56 firm fixed price purchase order to Advanced Cell Diagnostics, Inc., doing business as ACD, a division of Bio-Techne Corporation, doing business as Bio-Techne. The contract is for the delivery of RNA scope probes to the NIH campus in Bethesda, Maryland with performance from September 8 through September 16, 2016. As the largest biomedical research agency in the world, the NIH and...

<p>The National Institutes of Health Clinical Center awarded a purchase order to Advanced Cell Diagnostics, Inc. valued at $10,807.60 on August 22, 2018, for RNA probes and advanced cell diagnostics products. Performance is located in Newark, California. The order carries a firm fixed price, with an ultimate completion date of August 30, 2018. No set-aside category applies.</p>

The National Institute of Child Health and Human Development (NICHD), a civilian agency, awarded a firm-fixed-price purchase order contract worth $24,970.34 to Advanced Cell Diagnostics, Inc. (ACD), a for-profit manufacturer of molecular diagnostics products. The contract is for the supply of reagent kits and probes, specifically ACD's proprietary RNAscope technology, to support biomedical research efforts across various NIH institutes. ACD has been a longstanding partner for federal research...

The National Institutes of Health's National Institute of Child Health and Human Development awarded a $21,435 firm fixed price purchase order to Advanced Cell Diagnostics, Inc., doing business as ACD, a subsidiary of Bio-Techne Corporation, also doing business as Bio-Techne. The contract is for the delivery of RNAscope reagents, kits, and specific probes to support NICHD's research efforts. As the leading federal sponsor of biomedical research, NIH aims to uncover new knowledge that will lead...